Rank | Gene Set | Z-score |
---|---|---|
1 | drug transmembrane transport (GO:0006855) | 9.11741000 |
2 | urate metabolic process (GO:0046415) | 9.10302341 |
3 | regulation of plasminogen activation (GO:0010755) | 8.91469387 |
4 | lysine metabolic process (GO:0006553) | 7.72008304 |
5 | lysine catabolic process (GO:0006554) | 7.72008304 |
6 | aminoglycoside antibiotic metabolic process (GO:0030647) | 7.70756084 |
7 | drug transport (GO:0015893) | 7.66439673 |
8 | glyoxylate metabolic process (GO:0046487) | 7.48612146 |
9 | cysteine metabolic process (GO:0006534) | 6.99803501 |
10 | organic cation transport (GO:0015695) | 6.96950062 |
11 | folic acid-containing compound biosynthetic process (GO:0009396) | 6.75243621 |
12 | exogenous drug catabolic process (GO:0042738) | 6.70947058 |
13 | drug catabolic process (GO:0042737) | 6.70042505 |
14 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 6.56606257 |
15 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 6.56606257 |
16 | phosphate ion transport (GO:0006817) | 6.52795407 |
17 | L-phenylalanine catabolic process (GO:0006559) | 6.45102296 |
18 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.45102296 |
19 | L-phenylalanine metabolic process (GO:0006558) | 6.39485047 |
20 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.39485047 |
21 | purine nucleotide salvage (GO:0032261) | 6.35719186 |
22 | aromatic amino acid family catabolic process (GO:0009074) | 6.12417224 |
23 | indole-containing compound catabolic process (GO:0042436) | 5.81881909 |
24 | indolalkylamine catabolic process (GO:0046218) | 5.81881909 |
25 | tryptophan catabolic process (GO:0006569) | 5.81881909 |
26 | quaternary ammonium group transport (GO:0015697) | 5.76841146 |
27 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.70714058 |
28 | desmosome organization (GO:0002934) | 5.66905926 |
29 | phosphate ion transmembrane transport (GO:0035435) | 5.62995899 |
30 | adenosine metabolic process (GO:0046085) | 5.59986483 |
31 | response to mercury ion (GO:0046689) | 5.51321103 |
32 | serine family amino acid catabolic process (GO:0009071) | 5.51157056 |
33 | tryptophan metabolic process (GO:0006568) | 5.49846419 |
34 | short-chain fatty acid metabolic process (GO:0046459) | 5.46243054 |
35 | lipoprotein transport (GO:0042953) | 5.43443164 |
36 | aspartate family amino acid catabolic process (GO:0009068) | 5.37580645 |
37 | white fat cell differentiation (GO:0050872) | 5.34688622 |
38 | tricarboxylic acid metabolic process (GO:0072350) | 5.28457758 |
39 | regulation of vitamin metabolic process (GO:0030656) | 5.21439204 |
40 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 5.20013110 |
41 | serine family amino acid metabolic process (GO:0009069) | 5.08730608 |
42 | homocysteine metabolic process (GO:0050667) | 5.07844120 |
43 | branched-chain amino acid metabolic process (GO:0009081) | 5.07512261 |
44 | cellular modified amino acid catabolic process (GO:0042219) | 5.05220505 |
45 | microtubule nucleation (GO:0007020) | 4.98798858 |
46 | amino-acid betaine metabolic process (GO:0006577) | 4.96898661 |
47 | nonribosomal peptide biosynthetic process (GO:0019184) | 4.95039020 |
48 | kynurenine metabolic process (GO:0070189) | 4.77755595 |
49 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.75995774 |
50 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.75421545 |
51 | cellular ketone body metabolic process (GO:0046950) | 4.75083703 |
52 | valine metabolic process (GO:0006573) | 4.74977558 |
53 | sulfur amino acid catabolic process (GO:0000098) | 4.66809154 |
54 | 2-oxoglutarate metabolic process (GO:0006103) | 4.61079366 |
55 | alternative mRNA splicing, via spliceosome (GO:0000380) | 4.59956121 |
56 | negative regulation of DNA biosynthetic process (GO:2000279) | 4.57870727 |
57 | serine family amino acid biosynthetic process (GO:0009070) | 4.55325428 |
58 | glutathione biosynthetic process (GO:0006750) | 4.51662787 |
59 | aromatic amino acid family metabolic process (GO:0009072) | 4.51203135 |
60 | angiotensin maturation (GO:0002003) | 4.50718648 |
61 | fatty acid beta-oxidation (GO:0006635) | 4.50303728 |
62 | protein-chromophore linkage (GO:0018298) | 4.46079238 |
63 | alpha-amino acid catabolic process (GO:1901606) | 4.45365371 |
64 | cellular amino acid catabolic process (GO:0009063) | 4.44001055 |
65 | epoxygenase P450 pathway (GO:0019373) | 4.41978136 |
66 | galactose catabolic process (GO:0019388) | 4.38813136 |
67 | branched-chain amino acid catabolic process (GO:0009083) | 4.37580666 |
68 | glutamate metabolic process (GO:0006536) | 4.34034129 |
69 | acetyl-CoA metabolic process (GO:0006084) | 4.33485830 |
70 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.31979511 |
71 | proline metabolic process (GO:0006560) | 4.30188467 |
72 | pteridine-containing compound biosynthetic process (GO:0042559) | 4.29703114 |
73 | carnitine transport (GO:0015879) | 4.29191360 |
74 | amino-acid betaine transport (GO:0015838) | 4.29191360 |
75 | fatty acid oxidation (GO:0019395) | 4.28390496 |
76 | excretion (GO:0007588) | 4.21486518 |
77 | lipid oxidation (GO:0034440) | 4.20032577 |
78 | vitamin D metabolic process (GO:0042359) | 4.20002784 |
79 | glycoside metabolic process (GO:0016137) | 4.19922872 |
80 | carnitine metabolic process (GO:0009437) | 4.19831655 |
81 | L-serine metabolic process (GO:0006563) | 4.17800503 |
82 | bile acid biosynthetic process (GO:0006699) | 4.16995151 |
83 | fructose metabolic process (GO:0006000) | 4.14926643 |
84 | galactose metabolic process (GO:0006012) | 4.14318972 |
85 | cell migration involved in heart development (GO:0060973) | 4.14183010 |
86 | ketone body metabolic process (GO:1902224) | 4.10192905 |
87 | indolalkylamine metabolic process (GO:0006586) | 4.09058838 |
88 | benzene-containing compound metabolic process (GO:0042537) | 4.09033242 |
89 | phosphatidylglycerol biosynthetic process (GO:0006655) | 4.08345744 |
90 | renal absorption (GO:0070293) | 4.04677108 |
91 | phosphate ion homeostasis (GO:0055062) | 4.04532377 |
92 | trivalent inorganic anion homeostasis (GO:0072506) | 4.04532377 |
93 | toxin transport (GO:1901998) | 4.04357563 |
94 | glucuronate metabolic process (GO:0019585) | 4.02794010 |
95 | uronic acid metabolic process (GO:0006063) | 4.02794010 |
96 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.01544631 |
97 | carboxylic acid catabolic process (GO:0046395) | 3.99312563 |
98 | organic acid catabolic process (GO:0016054) | 3.99312563 |
99 | cellular glucuronidation (GO:0052695) | 3.99076228 |
100 | flavonoid metabolic process (GO:0009812) | 3.92913189 |
101 | fatty acid catabolic process (GO:0009062) | 3.92409425 |
102 | inner ear receptor cell development (GO:0060119) | 3.91313524 |
103 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.89657371 |
104 | amine catabolic process (GO:0009310) | 3.85975295 |
105 | cellular biogenic amine catabolic process (GO:0042402) | 3.85975295 |
106 | drug metabolic process (GO:0017144) | 3.84795502 |
107 | negative regulation of catenin import into nucleus (GO:0035414) | 3.84384475 |
108 | regulation of sequestering of triglyceride (GO:0010889) | 3.83359314 |
109 | monocarboxylic acid catabolic process (GO:0072329) | 3.82473385 |
110 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.82262016 |
111 | response to phenylpropanoid (GO:0080184) | 3.80538008 |
112 | urea cycle (GO:0000050) | 3.79280104 |
113 | urea metabolic process (GO:0019627) | 3.79129231 |
114 | aldehyde catabolic process (GO:0046185) | 3.78709290 |
115 | indole-containing compound metabolic process (GO:0042430) | 3.75456286 |
116 | negative regulation of Ras GTPase activity (GO:0034261) | 3.74069089 |
117 | nucleotide salvage (GO:0043173) | 3.71520573 |
118 | modified amino acid transport (GO:0072337) | 3.70367259 |
119 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.69940539 |
120 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.69940539 |
121 | primary amino compound metabolic process (GO:1901160) | 3.69870536 |
122 | regulation of triglyceride catabolic process (GO:0010896) | 3.67247579 |
123 | mitochondrial RNA metabolic process (GO:0000959) | 3.66594038 |
124 | glutathione metabolic process (GO:0006749) | 3.65946672 |
125 | regulation of tight junction assembly (GO:2000810) | 3.65822917 |
126 | nucleoside transmembrane transport (GO:1901642) | 3.64467555 |
127 | tetrahydrofolate metabolic process (GO:0046653) | 3.63659225 |
128 | COPII vesicle coating (GO:0048208) | 3.61081390 |
129 | glycosphingolipid catabolic process (GO:0046479) | 3.58855325 |
130 | peptide biosynthetic process (GO:0043043) | 3.57093446 |
131 | regulation of cholesterol esterification (GO:0010872) | 3.56403504 |
132 | folic acid-containing compound metabolic process (GO:0006760) | 3.55876567 |
133 | dicarboxylic acid metabolic process (GO:0043648) | 3.55130724 |
134 | metanephric nephron tubule development (GO:0072234) | 3.52908284 |
135 | metanephric tubule development (GO:0072170) | 3.52908284 |
136 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.50204323 |
137 | heme transport (GO:0015886) | 3.49420490 |
138 | sodium-independent organic anion transport (GO:0043252) | 3.49279798 |
139 | response to growth hormone (GO:0060416) | 3.48577343 |
140 | glutathione derivative biosynthetic process (GO:1901687) | 3.45499536 |
141 | glutathione derivative metabolic process (GO:1901685) | 3.45499536 |
142 | small molecule catabolic process (GO:0044282) | 3.45308977 |
143 | tyrosine metabolic process (GO:0006570) | 3.44987517 |
144 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.43860165 |
145 | regulation of cholesterol homeostasis (GO:2000188) | 3.43422837 |
146 | regulation of gonadotropin secretion (GO:0032276) | 3.42568812 |
147 | glycolipid catabolic process (GO:0019377) | 3.40336465 |
148 | nitrogen cycle metabolic process (GO:0071941) | 3.40244306 |
149 | biotin metabolic process (GO:0006768) | 3.38036571 |
150 | response to vitamin A (GO:0033189) | 3.36205810 |
151 | alpha-linolenic acid metabolic process (GO:0036109) | 3.35977825 |
152 | peptide catabolic process (GO:0043171) | 3.35730921 |
153 | glycine metabolic process (GO:0006544) | 3.35193833 |
154 | ethanol oxidation (GO:0006069) | 3.34058564 |
155 | sulfur amino acid metabolic process (GO:0000096) | 3.33766077 |
156 | hormone catabolic process (GO:0042447) | 3.31026210 |
157 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.30875700 |
158 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.30131364 |
159 | cochlea development (GO:0090102) | 3.29999849 |
160 | cartilage morphogenesis (GO:0060536) | 3.29991313 |
161 | histone H4-K12 acetylation (GO:0043983) | 3.29980027 |
162 | regulation of cholesterol storage (GO:0010885) | 3.27997439 |
163 | sulfur amino acid biosynthetic process (GO:0000097) | 3.20637548 |
164 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 3.12419780 |
165 | glycosylceramide metabolic process (GO:0006677) | 3.11652748 |
166 | bile acid metabolic process (GO:0008206) | 3.11400729 |
167 | regulation of endothelial cell differentiation (GO:0045601) | 3.05198773 |
168 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.02605495 |
169 | bile acid and bile salt transport (GO:0015721) | 3.01839794 |
170 | ceramide catabolic process (GO:0046514) | 2.99924540 |
171 | NADH metabolic process (GO:0006734) | 2.96019169 |
172 | alpha-amino acid biosynthetic process (GO:1901607) | 2.96001503 |
173 | IMP biosynthetic process (GO:0006188) | 2.94223551 |
174 | protein-lipid complex remodeling (GO:0034368) | 2.94216939 |
175 | macromolecular complex remodeling (GO:0034367) | 2.94216939 |
176 | plasma lipoprotein particle remodeling (GO:0034369) | 2.94216939 |
177 | lipoprotein metabolic process (GO:0042157) | 2.93583867 |
178 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.90887801 |
179 | omega-hydroxylase P450 pathway (GO:0097267) | 2.89478705 |
180 | polyamine biosynthetic process (GO:0006596) | 2.89470073 |
181 | pteridine-containing compound metabolic process (GO:0042558) | 2.78203612 |
182 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.77424649 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.51876593 |
2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.23516506 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.25732012 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.40191303 |
5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.29418489 |
6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.36587246 |
7 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.07305109 |
8 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.69152038 |
9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.55262735 |
10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.15004182 |
11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.95913733 |
12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.87579811 |
13 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.85933867 |
14 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.70560591 |
15 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.41275580 |
16 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.22065247 |
17 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.15186959 |
18 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.13691585 |
19 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.01324404 |
20 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 11.3366815 |
21 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.72297910 |
22 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.68383112 |
23 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.67685633 |
24 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.67533858 |
25 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.64640493 |
26 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.61989595 |
27 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.60976470 |
28 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.59591477 |
29 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.58518259 |
30 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.57533663 |
31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.57373747 |
32 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.57138755 |
33 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.50821929 |
34 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.50309171 |
35 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 1.47473724 |
36 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.46562216 |
37 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.42492009 |
38 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.42298309 |
39 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.42269692 |
40 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.41205991 |
41 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.40790201 |
42 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.39970226 |
43 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.33980948 |
44 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.33361438 |
45 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.31060720 |
46 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.29583765 |
47 | P300_27268052_Chip-Seq_Bcells_Human | 1.28763107 |
48 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.25988693 |
49 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.24926525 |
50 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.24808108 |
51 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.24502936 |
52 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.23709021 |
53 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.20061810 |
54 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.16748161 |
55 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.15372755 |
56 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.13992631 |
57 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.13799576 |
58 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 1.12996783 |
59 | * ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.12948024 |
60 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.12678237 |
61 | * NCOR_22424771_ChIP-Seq_293T_Human | 1.11547108 |
62 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.10679432 |
63 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06440607 |
64 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.03695204 |
65 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.02480990 |
66 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.02172965 |
67 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01651769 |
68 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.01040512 |
69 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.98138146 |
70 | VDR_22108803_ChIP-Seq_LS180_Human | 0.97881272 |
71 | SA1_27219007_Chip-Seq_Bcells_Human | 0.96746630 |
72 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.96138568 |
73 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95845923 |
74 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.95569964 |
75 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95070139 |
76 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.94964956 |
77 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.93868636 |
78 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.93826295 |
79 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.91737885 |
80 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.91526686 |
81 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.90864213 |
82 | * SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90343804 |
83 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.89599194 |
84 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89408414 |
85 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.87877496 |
86 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.87820894 |
87 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.87816076 |
88 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.87034027 |
89 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.86445640 |
90 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.85702547 |
91 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.85311396 |
92 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.85011927 |
93 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.84674190 |
94 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.84416484 |
95 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.84193701 |
96 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.84011008 |
97 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.83756930 |
98 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.83505648 |
99 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.83505648 |
100 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.82656010 |
101 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.81197462 |
102 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80533563 |
103 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.80313590 |
104 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.79983645 |
105 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.79480269 |
106 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.79032173 |
107 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.78856834 |
108 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.78780164 |
109 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.78672175 |
110 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.77610342 |
111 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.77574001 |
112 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.77484398 |
113 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.77389396 |
114 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.76626784 |
115 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.76197203 |
116 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.76022412 |
117 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.75492369 |
118 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.75150872 |
119 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.73913588 |
120 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.73172914 |
121 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.72591948 |
122 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.72476477 |
123 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.71936623 |
124 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.70908917 |
125 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.70025930 |
126 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.69438810 |
127 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.68146755 |
128 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.66884951 |
129 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.66551967 |
130 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.66245805 |
131 | AR_20517297_ChIP-Seq_VCAP_Human | 0.65948276 |
132 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.65539679 |
133 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.64840872 |
134 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.64694721 |
135 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.64527608 |
136 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.63099851 |
137 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.62949946 |
138 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.61815642 |
139 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.61780476 |
140 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.61737886 |
141 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.61737886 |
142 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.61728714 |
143 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.61603251 |
144 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.61482853 |
145 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.61433376 |
146 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.61305032 |
147 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.60385760 |
148 | GATA2_19941826_ChIP-Seq_K562_Human | 0.60351339 |
149 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.60182761 |
150 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.60138929 |
151 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.58838624 |
152 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.56530329 |
153 | CBP_21632823_ChIP-Seq_H3396_Human | 0.56087621 |
154 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.55746780 |
155 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.55443525 |
156 | GATA1_22025678_ChIP-Seq_K562_Human | 0.54897424 |
157 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.54531533 |
158 | P68_20966046_ChIP-Seq_HELA_Human | 0.54516118 |
159 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.53924930 |
160 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.53672756 |
161 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.51797113 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 8.58168041 |
2 | MP0002139_abnormal_hepatobiliary_system | 6.91656230 |
3 | MP0003183_abnormal_peptide_metabolism | 4.92041649 |
4 | MP0005332_abnormal_amino_acid | 4.69237356 |
5 | MP0004043_abnormal_pH_regulation | 4.44496616 |
6 | MP0004019_abnormal_vitamin_homeostasis | 4.35296873 |
7 | MP0008875_abnormal_xenobiotic_pharmacok | 4.21277566 |
8 | MP0005085_abnormal_gallbladder_physiolo | 4.08203514 |
9 | MP0005365_abnormal_bile_salt | 3.90138826 |
10 | MP0003195_calcinosis | 3.54936305 |
11 | MP0002138_abnormal_hepatobiliary_system | 3.45487363 |
12 | MP0009643_abnormal_urine_homeostasis | 3.29703310 |
13 | MP0003252_abnormal_bile_duct | 3.10704623 |
14 | MP0005646_abnormal_pituitary_gland | 3.09264817 |
15 | MP0002396_abnormal_hematopoietic_system | 2.91607951 |
16 | MP0003806_abnormal_nucleotide_metabolis | 2.79096958 |
17 | MP0001765_abnormal_ion_homeostasis | 2.73054194 |
18 | MP0000013_abnormal_adipose_tissue | 2.64137493 |
19 | MP0005636_abnormal_mineral_homeostasis | 2.57053823 |
20 | MP0001756_abnormal_urination | 2.30407744 |
21 | MP0002136_abnormal_kidney_physiology | 2.21998403 |
22 | MP0008995_early_reproductive_senescence | 2.08251342 |
23 | MP0003186_abnormal_redox_activity | 1.87899464 |
24 | MP0002736_abnormal_nociception_after | 1.83559521 |
25 | MP0010329_abnormal_lipoprotein_level | 1.83083096 |
26 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.80439926 |
27 | MP0003878_abnormal_ear_physiology | 1.78638293 |
28 | MP0005377_hearing/vestibular/ear_phenot | 1.78638293 |
29 | MP0005058_abnormal_lysosome_morphology | 1.76179273 |
30 | MP0005319_abnormal_enzyme/_coenzyme | 1.76158131 |
31 | MP0001666_abnormal_nutrient_absorption | 1.75433226 |
32 | MP0000516_abnormal_urinary_system | 1.63981398 |
33 | MP0005367_renal/urinary_system_phenotyp | 1.63981398 |
34 | MP0001958_emphysema | 1.63676904 |
35 | MP0009697_abnormal_copulation | 1.63113486 |
36 | MP0003191_abnormal_cellular_cholesterol | 1.56259421 |
37 | MP0008872_abnormal_physiological_respon | 1.53099211 |
38 | MP0004185_abnormal_adipocyte_glucose | 1.47091478 |
39 | MP0002118_abnormal_lipid_homeostasis | 1.46564907 |
40 | MP0005084_abnormal_gallbladder_morpholo | 1.46176968 |
41 | MP0005451_abnormal_body_composition | 1.41834356 |
42 | MP0001764_abnormal_homeostasis | 1.40750351 |
43 | MP0002938_white_spotting | 1.35306989 |
44 | MP0005083_abnormal_biliary_tract | 1.34130077 |
45 | MP0006036_abnormal_mitochondrial_physio | 1.33930652 |
46 | MP0000678_abnormal_parathyroid_gland | 1.32908845 |
47 | MP0000609_abnormal_liver_physiology | 1.30461599 |
48 | MP0002132_abnormal_respiratory_system | 1.29755266 |
49 | MP0002876_abnormal_thyroid_physiology | 1.24602260 |
50 | MP0000538_abnormal_urinary_bladder | 1.22865228 |
51 | MP0009840_abnormal_foam_cell | 1.20171359 |
52 | MP0005670_abnormal_white_adipose | 1.14837005 |
53 | MP0000003_abnormal_adipose_tissue | 1.10152002 |
54 | MP0010155_abnormal_intestine_physiology | 1.09742496 |
55 | MP0008961_abnormal_basal_metabolism | 1.05441656 |
56 | MP0004885_abnormal_endolymph | 1.05021064 |
57 | MP0002928_abnormal_bile_duct | 1.01781578 |
58 | MP0005535_abnormal_body_temperature | 1.00850690 |
59 | MP0001968_abnormal_touch/_nociception | 0.94238728 |
60 | MP0009379_abnormal_foot_pigmentation | 0.93757194 |
61 | MP0005666_abnormal_adipose_tissue | 0.91702458 |
62 | MP0000230_abnormal_systemic_arterial | 0.91634645 |
63 | MP0000534_abnormal_ureter_morphology | 0.91234949 |
64 | MP0001835_abnormal_antigen_presentation | 0.91000526 |
65 | MP0002168_other_aberrant_phenotype | 0.88960250 |
66 | MP0002095_abnormal_skin_pigmentation | 0.88428776 |
67 | MP0009642_abnormal_blood_homeostasis | 0.88409288 |
68 | MP0001800_abnormal_humoral_immune | 0.87905397 |
69 | MP0004147_increased_porphyrin_level | 0.87047515 |
70 | MP0000598_abnormal_liver_morphology | 0.86264669 |
71 | MP0009764_decreased_sensitivity_to | 0.84825018 |
72 | MP0002135_abnormal_kidney_morphology | 0.82202831 |
73 | MP0003300_gastrointestinal_ulcer | 0.82047666 |
74 | MP0009115_abnormal_fat_cell | 0.80230823 |
75 | MP0002735_abnormal_chemical_nociception | 0.77959997 |
76 | MP0001661_extended_life_span | 0.77294200 |
77 | MP0008469_abnormal_protein_level | 0.75187172 |
78 | MP0005409_darkened_coat_color | 0.73784389 |
79 | MP0003638_abnormal_response/metabolism_ | 0.72620475 |
80 | MP0002089_abnormal_postnatal_growth/wei | 0.72408733 |
81 | MP0005408_hypopigmentation | 0.70690028 |
82 | MP0003705_abnormal_hypodermis_morpholog | 0.70053261 |
83 | MP0004264_abnormal_extraembryonic_tissu | 0.69165812 |
84 | MP0005000_abnormal_immune_tolerance | 0.69051241 |
85 | MP0003646_muscle_fatigue | 0.67989842 |
86 | MP0001851_eye_inflammation | 0.67759901 |
87 | MP0003045_fibrosis | 0.67313257 |
88 | MP0005164_abnormal_response_to | 0.65489461 |
89 | MP0002148_abnormal_hypersensitivity_rea | 0.65086138 |
90 | MP0005220_abnormal_exocrine_pancreas | 0.64987290 |
91 | MP0003866_abnormal_defecation | 0.64789995 |
92 | MP0002896_abnormal_bone_mineralization | 0.64549184 |
93 | MP0000249_abnormal_blood_vessel | 0.64386697 |
94 | MP0002078_abnormal_glucose_homeostasis | 0.63050291 |
95 | MP0005166_decreased_susceptibility_to | 0.62375104 |
96 | MP0002796_impaired_skin_barrier | 0.62113516 |
97 | MP0001986_abnormal_taste_sensitivity | 0.61902801 |
98 | MP0003329_amyloid_beta_deposits | 0.61547958 |
99 | MP0009333_abnormal_splenocyte_physiolog | 0.61315055 |
100 | MP0006035_abnormal_mitochondrial_morpho | 0.60181319 |
101 | MP0002006_tumorigenesis | 0.59688326 |
102 | MP0005395_other_phenotype | 0.58512778 |
103 | MP0000747_muscle_weakness | 0.58365380 |
104 | MP0003172_abnormal_lysosome_physiology | 0.56624524 |
105 | MP0001533_abnormal_skeleton_physiology | 0.56324269 |
106 | MP0000681_abnormal_thyroid_gland | 0.54974693 |
107 | MP0005551_abnormal_eye_electrophysiolog | 0.52799721 |
108 | MP0003718_maternal_effect | 0.52783826 |
109 | MP0001270_distended_abdomen | 0.52278841 |
110 | MP0002723_abnormal_immune_serum | 0.52103019 |
111 | MP0003868_abnormal_feces_composition | 0.51562002 |
112 | MP0002419_abnormal_innate_immunity | 0.51341643 |
113 | MP0010234_abnormal_vibrissa_follicle | 0.51272285 |
114 | MP0002452_abnormal_antigen_presenting | 0.50807852 |
115 | MP0001944_abnormal_pancreas_morphology | 0.49909129 |
116 | MP0000604_amyloidosis | 0.49178022 |
117 | MP0002971_abnormal_brown_adipose | 0.48721775 |
118 | MP0005376_homeostasis/metabolism_phenot | 0.48655302 |
119 | MP0001663_abnormal_digestive_system | 0.48510748 |
120 | MP0009765_abnormal_xenobiotic_induced | 0.47478034 |
121 | MP0000371_diluted_coat_color | 0.46430408 |
122 | MP0003953_abnormal_hormone_level | 0.46291978 |
123 | MP0003436_decreased_susceptibility_to | 0.46015441 |
124 | MP0003724_increased_susceptibility_to | 0.45012572 |
125 | MP0003959_abnormal_lean_body | 0.43532189 |
126 | MP0009763_increased_sensitivity_to | 0.43409269 |
127 | MP0005647_abnormal_sex_gland | 0.42756655 |
128 | MP0003283_abnormal_digestive_organ | 0.41248028 |
129 | MP0005501_abnormal_skin_physiology | 0.40929383 |
130 | MP0005266_abnormal_metabolism | 0.40678042 |
131 | MP0009672_abnormal_birth_weight | 0.39860136 |
132 | MP0005167_abnormal_blood-brain_barrier | 0.39164440 |
133 | MP0002837_dystrophic_cardiac_calcinosis | 0.36616678 |
134 | MP0005165_increased_susceptibility_to | 0.36088933 |
135 | MP0003879_abnormal_hair_cell | 0.35688806 |
136 | MP0005375_adipose_tissue_phenotype | 0.35599837 |
137 | MP0002115_abnormal_skeleton_extremities | 0.32371599 |
138 | MP0005334_abnormal_fat_pad | 0.32261235 |
139 | MP0003690_abnormal_glial_cell | 0.31837954 |
140 | MP0002069_abnormal_eating/drinking_beha | 0.30931878 |
141 | MP0003221_abnormal_cardiomyocyte_apopto | 0.29770942 |
142 | MP0005330_cardiomyopathy | 0.29516430 |
143 | MP0004130_abnormal_muscle_cell | 0.29269431 |
144 | MP0002098_abnormal_vibrissa_morphology | 0.28661110 |
145 | MP0003075_altered_response_to | 0.28638592 |
146 | MP0008874_decreased_physiological_sensi | 0.26617217 |
147 | MP0001845_abnormal_inflammatory_respons | 0.25970623 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 7.38777145 |
2 | Abnormality of alanine metabolism (HP:0010916) | 7.38777145 |
3 | Hyperalaninemia (HP:0003348) | 7.38777145 |
4 | Gout (HP:0001997) | 6.64432296 |
5 | Congenital sensorineural hearing impairment (HP:0008527) | 5.84463864 |
6 | Increased circulating renin level (HP:0000848) | 5.69046938 |
7 | Metabolic alkalosis (HP:0200114) | 5.58781017 |
8 | Hypokalemic alkalosis (HP:0001949) | 5.57833427 |
9 | Spontaneous hematomas (HP:0007420) | 5.40990516 |
10 | Constricted visual fields (HP:0001133) | 5.32666178 |
11 | Hyperglycinuria (HP:0003108) | 5.31284989 |
12 | Hypomagnesemia (HP:0002917) | 5.24331405 |
13 | Proximal tubulopathy (HP:0000114) | 5.20295430 |
14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.19689916 |
15 | Hyperactive renin-angiotensin system (HP:0000841) | 5.16060148 |
16 | Polyuria (HP:0000103) | 5.08463871 |
17 | Abnormal urine output (HP:0012590) | 4.88955496 |
18 | Abnormality of chloride homeostasis (HP:0011422) | 4.85025688 |
19 | Increased purine levels (HP:0004368) | 4.80149931 |
20 | Hyperuricemia (HP:0002149) | 4.80149931 |
21 | Esophageal varix (HP:0002040) | 4.78965592 |
22 | Abnormality of renal excretion (HP:0011036) | 4.72024172 |
23 | Abnormality of purine metabolism (HP:0004352) | 4.68507091 |
24 | Abnormality of glycine metabolism (HP:0010895) | 4.60990278 |
25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.60990278 |
26 | White forelock (HP:0002211) | 4.54048886 |
27 | Abnormal umbilical cord blood vessels (HP:0011403) | 4.45401845 |
28 | Single umbilical artery (HP:0001195) | 4.45401845 |
29 | Abnormality of the fetal cardiovascular system (HP:0010948) | 4.45401845 |
30 | Abnormality of magnesium homeostasis (HP:0004921) | 4.44940801 |
31 | Generalized aminoaciduria (HP:0002909) | 4.39070596 |
32 | Alkalosis (HP:0001948) | 4.26739256 |
33 | Ketosis (HP:0001946) | 4.22018999 |
34 | Ketoacidosis (HP:0001993) | 4.19409107 |
35 | Patchy hypopigmentation of hair (HP:0011365) | 4.18670631 |
36 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.11804097 |
37 | Abnormal drinking behavior (HP:0030082) | 4.08398060 |
38 | Polydipsia (HP:0001959) | 4.08398060 |
39 | Conjugated hyperbilirubinemia (HP:0002908) | 4.00321026 |
40 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.91369884 |
41 | Abnormality of nucleobase metabolism (HP:0010932) | 3.76266450 |
42 | Glycosuria (HP:0003076) | 3.75403962 |
43 | Abnormality of urine glucose concentration (HP:0011016) | 3.75403962 |
44 | Myocardial infarction (HP:0001658) | 3.70396007 |
45 | Hyperglycinemia (HP:0002154) | 3.70072962 |
46 | Conjunctival telangiectasia (HP:0000524) | 3.59309583 |
47 | Anorexia (HP:0002039) | 3.58958102 |
48 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.58253266 |
49 | Renal salt wasting (HP:0000127) | 3.57417489 |
50 | Abnormality of renin-angiotensin system (HP:0000847) | 3.56292780 |
51 | Ileus (HP:0002595) | 3.54356370 |
52 | Hyperaldosteronism (HP:0000859) | 3.51301856 |
53 | Hyperammonemia (HP:0001987) | 3.50468437 |
54 | Tetany (HP:0001281) | 3.47908246 |
55 | Delayed CNS myelination (HP:0002188) | 3.45997623 |
56 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.41728782 |
57 | Pigmentary retinal degeneration (HP:0001146) | 3.39869725 |
58 | Intrahepatic cholestasis (HP:0001406) | 3.31477575 |
59 | Pulmonary embolism (HP:0002204) | 3.29966903 |
60 | Action tremor (HP:0002345) | 3.28513271 |
61 | Hypercalciuria (HP:0002150) | 3.27477842 |
62 | Renal tubular acidosis (HP:0001947) | 3.21362800 |
63 | Hyperphosphaturia (HP:0003109) | 3.20329409 |
64 | Homocystinuria (HP:0002156) | 3.16067113 |
65 | Abnormality of homocysteine metabolism (HP:0010919) | 3.16067113 |
66 | Vascular calcification (HP:0004934) | 3.14005238 |
67 | Hydroxyprolinuria (HP:0003080) | 3.12317238 |
68 | Abnormality of proline metabolism (HP:0010907) | 3.12317238 |
69 | Systemic lupus erythematosus (HP:0002725) | 3.09679408 |
70 | Xanthomatosis (HP:0000991) | 3.09152008 |
71 | Dicarboxylic aciduria (HP:0003215) | 3.06809132 |
72 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.06809132 |
73 | Thrombophlebitis (HP:0004418) | 3.03991610 |
74 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.02990215 |
75 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.99848225 |
76 | Abnormal urine phosphate concentration (HP:0012599) | 2.97206473 |
77 | Chronic otitis media (HP:0000389) | 2.95491331 |
78 | Visceral angiomatosis (HP:0100761) | 2.93049555 |
79 | Hypoalphalipoproteinemia (HP:0003233) | 2.90765120 |
80 | Nephrolithiasis (HP:0000787) | 2.90098843 |
81 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.87833225 |
82 | Metabolic acidosis (HP:0001942) | 2.87783934 |
83 | Gingival bleeding (HP:0000225) | 2.86220960 |
84 | Rickets (HP:0002748) | 2.81072070 |
85 | Cardiovascular calcification (HP:0011915) | 2.79797985 |
86 | Abnormality of the umbilical cord (HP:0010881) | 2.76689547 |
87 | Chronic diarrhea (HP:0002028) | 2.71740033 |
88 | Hypokalemia (HP:0002900) | 2.70249669 |
89 | Hypolipoproteinemia (HP:0010981) | 2.69610012 |
90 | Hypophosphatemia (HP:0002148) | 2.69531931 |
91 | Delayed epiphyseal ossification (HP:0002663) | 2.68635426 |
92 | Hemangiomatosis (HP:0007461) | 2.68537010 |
93 | Fatigue (HP:0012378) | 2.68518563 |
94 | Birth length less than 3rd percentile (HP:0003561) | 2.67094167 |
95 | Lethargy (HP:0001254) | 2.62981999 |
96 | Vomiting (HP:0002013) | 2.61811117 |
97 | Oligomenorrhea (HP:0000876) | 2.59438316 |
98 | Malnutrition (HP:0004395) | 2.58214711 |
99 | Nephrocalcinosis (HP:0000121) | 2.55829097 |
100 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.52751843 |
101 | Epidermoid cyst (HP:0200040) | 2.51757895 |
102 | Vacuolated lymphocytes (HP:0001922) | 2.51237535 |
103 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.47523676 |
104 | Heterochromia iridis (HP:0001100) | 2.46329712 |
105 | Enlarged kidneys (HP:0000105) | 2.45714359 |
106 | Hypobetalipoproteinemia (HP:0003563) | 2.42435866 |
107 | Megaloblastic anemia (HP:0001889) | 2.41258785 |
108 | Abnormality of serum amino acid levels (HP:0003112) | 2.41199287 |
109 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.40038491 |
110 | Methylmalonic aciduria (HP:0012120) | 2.34536333 |
111 | Myopathic facies (HP:0002058) | 2.34003915 |
112 | Confusion (HP:0001289) | 2.33347633 |
113 | Hypoglycemic coma (HP:0001325) | 2.33272352 |
114 | Widely patent fontanelles and sutures (HP:0004492) | 2.31053293 |
115 | Abnormality of potassium homeostasis (HP:0011042) | 2.30435940 |
116 | Sensorimotor neuropathy (HP:0007141) | 2.29042761 |
117 | Poor speech (HP:0002465) | 2.26941358 |
118 | Metaphyseal cupping (HP:0003021) | 2.26931377 |
119 | Complement deficiency (HP:0004431) | 2.26926673 |
120 | Irritability (HP:0000737) | 2.26131916 |
121 | Petechiae (HP:0000967) | 2.25410013 |
122 | Chorioretinal atrophy (HP:0000533) | 2.23734470 |
123 | Arterial thrombosis (HP:0004420) | 2.22392663 |
124 | Abnormal tarsal ossification (HP:0008369) | 2.22003032 |
125 | Biconcave vertebral bodies (HP:0004586) | 2.20716207 |
126 | Neonatal onset (HP:0003623) | 2.18064363 |
127 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.17206895 |
128 | Deep venous thrombosis (HP:0002625) | 2.14374610 |
129 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.13128108 |
130 | Dehydration (HP:0001944) | 2.13082342 |
131 | Pancreatitis (HP:0001733) | 2.12379559 |
132 | Nausea (HP:0002018) | 2.11234090 |
133 | Attenuation of retinal blood vessels (HP:0007843) | 2.10212974 |
134 | Polygenic inheritance (HP:0010982) | 2.09837373 |
135 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.09789120 |
136 | Late onset (HP:0003584) | 2.08792342 |
137 | Cavernous hemangioma (HP:0001048) | 2.04330653 |
138 | Abnormality of renal resorption (HP:0011038) | 2.04166179 |
139 | Toxemia of pregnancy (HP:0100603) | 2.03829509 |
140 | Renal tubular dysfunction (HP:0000124) | 2.03549972 |
141 | Elevated alkaline phosphatase (HP:0003155) | 2.03401754 |
142 | Hepatocellular carcinoma (HP:0001402) | 2.03393224 |
143 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.00659326 |
144 | Symptomatic seizures (HP:0011145) | 2.00258917 |
145 | Spastic diplegia (HP:0001264) | 1.97360925 |
146 | Focal segmental glomerulosclerosis (HP:0000097) | 1.95781444 |
147 | Lymphangioma (HP:0100764) | 1.93800146 |
148 | Cerebral edema (HP:0002181) | 1.93632924 |
149 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.93615809 |
150 | Facial shape deformation (HP:0011334) | 1.93515224 |
151 | Potter facies (HP:0002009) | 1.93515224 |
152 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.91785166 |
153 | Fat malabsorption (HP:0002630) | 1.91287095 |
154 | Cone-rod dystrophy (HP:0000548) | 1.90557845 |
155 | Chronic sinusitis (HP:0011109) | 1.88057009 |
156 | Abnormality of vitamin B metabolism (HP:0004340) | 1.85242071 |
157 | Hypophosphatemic rickets (HP:0004912) | 1.84733489 |
158 | Hyponatremia (HP:0002902) | 1.82743084 |
159 | Abnormality of sodium homeostasis (HP:0010931) | 1.78427199 |
160 | Hyperbilirubinemia (HP:0002904) | 1.74986148 |
161 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.74736676 |
162 | Thin bony cortex (HP:0002753) | 1.74169895 |
163 | Glomerulosclerosis (HP:0000096) | 1.72141019 |
164 | Axonal loss (HP:0003447) | 1.71937800 |
165 | Chondrocalcinosis (HP:0000934) | 1.70496272 |
Rank | Gene Set | Z-score |
---|---|---|
1 | WNK4 | 8.17784481 |
2 | WNK3 | 6.88037253 |
3 | OXSR1 | 6.25661420 |
4 | ACVR1B | 6.21756756 |
5 | BCKDK | 5.21177160 |
6 | JAK3 | 4.01674419 |
7 | STK39 | 3.63001647 |
8 | CDK9 | 3.50504262 |
9 | FGR | 3.45112857 |
10 | MAP4K1 | 3.04219273 |
11 | STK38L | 2.87348336 |
12 | RPS6KB2 | 2.74168305 |
13 | PDK4 | 2.27436993 |
14 | PDK3 | 2.27436993 |
15 | NEK1 | 2.24538930 |
16 | EPHB2 | 2.03556708 |
17 | FGFR4 | 2.02236583 |
18 | NTRK2 | 2.01775566 |
19 | CCNB1 | 1.86151090 |
20 | SGK494 | 1.75235994 |
21 | SGK223 | 1.75235994 |
22 | MST1R | 1.74700284 |
23 | WNK1 | 1.73767694 |
24 | NTRK3 | 1.57815481 |
25 | PDK2 | 1.55771493 |
26 | STK38 | 1.37390090 |
27 | ERN1 | 1.34294828 |
28 | BMPR2 | 1.30911302 |
29 | PINK1 | 1.27690074 |
30 | PRKG2 | 1.24749769 |
31 | MAP2K1 | 1.23369801 |
32 | LMTK2 | 1.19698887 |
33 | RIPK4 | 1.18172190 |
34 | KIT | 1.17862250 |
35 | GRK6 | 1.15992087 |
36 | SYK | 1.10674057 |
37 | EPHB1 | 1.10429619 |
38 | SMG1 | 1.04566016 |
39 | ADRBK1 | 1.04318482 |
40 | CSF1R | 0.98526139 |
41 | TIE1 | 0.97096617 |
42 | NEK6 | 0.95390939 |
43 | LRRK2 | 0.94508870 |
44 | CSNK1A1 | 0.93667000 |
45 | SIK1 | 0.88983266 |
46 | SGK3 | 0.88947112 |
47 | ABL2 | 0.88095606 |
48 | GSK3A | 0.85852765 |
49 | TRIB3 | 0.85784307 |
50 | MAPK11 | 0.85098108 |
51 | SGK2 | 0.84216142 |
52 | MAP3K7 | 0.80382591 |
53 | DYRK1B | 0.78626462 |
54 | VRK2 | 0.78066356 |
55 | MST4 | 0.78001382 |
56 | TESK2 | 0.77337444 |
57 | PTK6 | 0.75252693 |
58 | RPS6KB1 | 0.75139132 |
59 | PIK3CA | 0.73944728 |
60 | INSRR | 0.72429954 |
61 | MAP3K3 | 0.68973265 |
62 | TEC | 0.67243834 |
63 | ERBB4 | 0.66868655 |
64 | PTK2 | 0.66561984 |
65 | BTK | 0.65965341 |
66 | IRAK4 | 0.64526913 |
67 | IKBKB | 0.62586815 |
68 | LYN | 0.62338884 |
69 | PRKAA2 | 0.62184418 |
70 | MAP2K3 | 0.61865520 |
71 | MET | 0.61585983 |
72 | MAP2K4 | 0.61545494 |
73 | PRKAA1 | 0.60570106 |
74 | TGFBR2 | 0.59256848 |
75 | PDPK1 | 0.57228690 |
76 | FES | 0.56503955 |
77 | LCK | 0.54809851 |
78 | CAMK2B | 0.53149409 |
79 | LATS1 | 0.52178747 |
80 | FRK | 0.52085261 |
81 | CDK7 | 0.52048231 |
82 | SGK1 | 0.48109904 |
83 | CDK6 | 0.47420829 |
84 | PRKCZ | 0.46625837 |
85 | PKN2 | 0.46284317 |
86 | CAMK2D | 0.46215829 |
87 | PAK4 | 0.44922005 |
88 | MATK | 0.44460451 |
89 | CAMK1 | 0.43415049 |
90 | RIPK1 | 0.43171589 |
91 | MYLK | 0.42279675 |
92 | KDR | 0.41792679 |
93 | AURKA | 0.40024677 |
94 | PAK3 | 0.39383554 |
95 | RPS6KA1 | 0.39373224 |
96 | ITK | 0.39355358 |
97 | JAK2 | 0.38518168 |
98 | MAP3K11 | 0.38298021 |
99 | NME2 | 0.38262752 |
100 | GRK1 | 0.37277211 |
101 | PDK1 | 0.37179814 |
102 | IRAK3 | 0.36424618 |
103 | EGFR | 0.35425116 |
104 | INSR | 0.35146356 |
105 | HIPK2 | 0.34721391 |
106 | PIK3CG | 0.34533402 |
107 | MAP3K14 | 0.34375837 |
108 | MAPK15 | 0.33642622 |
109 | PRKACG | 0.33461433 |
110 | TNK2 | 0.32610184 |
111 | TLK1 | 0.31050301 |
112 | MAPK12 | 0.30964436 |
113 | IKBKE | 0.30582384 |
114 | PRKCI | 0.28793760 |
115 | SRC | 0.28534054 |
116 | NEK9 | 0.28493799 |
117 | IRAK2 | 0.28310143 |
118 | FER | 0.28027005 |
119 | UHMK1 | 0.27932578 |
120 | PTK2B | 0.27689535 |
121 | EPHA2 | 0.26518994 |
122 | MAPKAPK2 | 0.26431522 |
123 | TYK2 | 0.26378966 |
124 | PRKCE | 0.26166127 |
125 | DAPK1 | 0.25514833 |
126 | MAP3K13 | 0.24519923 |
127 | PRKCD | 0.24419252 |
128 | MAP2K6 | 0.24246864 |
129 | STK10 | 0.23160310 |
130 | SCYL2 | 0.23122615 |
131 | MAP3K10 | 0.23088071 |
132 | STK24 | 0.22904330 |
133 | NUAK1 | 0.22442147 |
134 | CDK19 | 0.22275871 |
135 | FYN | 0.22212510 |
136 | STK11 | 0.20233185 |
137 | MAPK4 | 0.19877298 |
138 | TBK1 | 0.18354059 |
139 | MAP3K2 | 0.17901993 |
140 | AKT2 | 0.17390726 |
141 | PRKCA | 0.16746398 |
142 | CSK | 0.15976670 |
143 | PRKD2 | 0.15878379 |
144 | PRKCQ | 0.13984068 |
145 | IRAK1 | 0.13255758 |
146 | PRKACA | 0.12795935 |
147 | BMX | 0.12578758 |
148 | PIM1 | 0.12528136 |
149 | CAMK4 | 0.11759423 |
150 | PRKCH | 0.11312688 |
151 | CSNK1G1 | 0.10535975 |
152 | ERBB2 | 0.09815563 |
153 | MTOR | 0.09727674 |
154 | CAMK2G | 0.09358790 |
155 | IGF1R | 0.09178889 |
156 | DAPK2 | 0.08693541 |
157 | MAP2K2 | 0.08416024 |
158 | TAOK3 | 0.08411782 |
159 | MAP3K6 | 0.08102519 |
160 | EPHA4 | 0.07875608 |
161 | FLT3 | 0.06741321 |
162 | PRKCG | 0.06308198 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.64504688 |
2 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.47539592 |
3 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.20280550 |
4 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.19408263 |
5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.11267999 |
6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.08027696 |
7 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.97335475 |
8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.83678348 |
9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.54973450 |
10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.53367936 |
11 | Peroxisome_Homo sapiens_hsa04146 | 2.52965590 |
12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.51535387 |
13 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.51178866 |
14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.49647211 |
15 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.49042940 |
16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.37459665 |
17 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.22441458 |
18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.13310892 |
19 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.98389650 |
20 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.96279805 |
21 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.93593106 |
22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.93536936 |
23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.90072179 |
24 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.85102953 |
25 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.84354952 |
26 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.67595489 |
27 | Bile secretion_Homo sapiens_hsa04976 | 1.61203681 |
28 | Carbon metabolism_Homo sapiens_hsa01200 | 1.59930606 |
29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.48956677 |
30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.48894272 |
31 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.47345693 |
32 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.41503179 |
33 | Asthma_Homo sapiens_hsa05310 | 1.41242954 |
34 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.39091203 |
35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.38509547 |
36 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.36025157 |
37 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.35923868 |
38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.35793210 |
39 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.29026622 |
40 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.28628591 |
41 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.27754063 |
42 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.20447130 |
43 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.18455014 |
44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.17908992 |
45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.16388929 |
46 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.15134135 |
47 | Lysine degradation_Homo sapiens_hsa00310 | 1.13364299 |
48 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.12680182 |
49 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.08223663 |
50 | Allograft rejection_Homo sapiens_hsa05330 | 1.07653419 |
51 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.04158518 |
52 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.03599950 |
53 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.01996359 |
54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.01237904 |
55 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.00615525 |
56 | Retinol metabolism_Homo sapiens_hsa00830 | 0.98374717 |
57 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.93574413 |
58 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.88225141 |
59 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.87126271 |
60 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.80638808 |
61 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.76338882 |
62 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.73928963 |
63 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.72785224 |
64 | Other glycan degradation_Homo sapiens_hsa00511 | 0.71962225 |
65 | GABAergic synapse_Homo sapiens_hsa04727 | 0.71384267 |
66 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.69970528 |
67 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.69392610 |
68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68902627 |
69 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.67745583 |
70 | Morphine addiction_Homo sapiens_hsa05032 | 0.67478148 |
71 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.66780994 |
72 | Mineral absorption_Homo sapiens_hsa04978 | 0.65696466 |
73 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.64746967 |
74 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.63807835 |
75 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.63033110 |
76 | Sulfur relay system_Homo sapiens_hsa04122 | 0.60507850 |
77 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.58522149 |
78 | Metabolic pathways_Homo sapiens_hsa01100 | 0.57147772 |
79 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.56027600 |
80 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.52639268 |
81 | ABC transporters_Homo sapiens_hsa02010 | 0.51489801 |
82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50342559 |
83 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.48262446 |
84 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.47747450 |
85 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.46100383 |
86 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.41839525 |
87 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.40441137 |
88 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.39786147 |
89 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.37600950 |
90 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.37568029 |
91 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.36493728 |
92 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.35776232 |
93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.33751502 |
94 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.33225332 |
95 | Nicotine addiction_Homo sapiens_hsa05033 | 0.32159943 |
96 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.30556562 |
97 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.30457375 |
98 | Lysosome_Homo sapiens_hsa04142 | 0.29162716 |
99 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.28158430 |
100 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.28123655 |
101 | Pertussis_Homo sapiens_hsa05133 | 0.27464807 |
102 | Base excision repair_Homo sapiens_hsa03410 | 0.27255933 |
103 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.27150631 |
104 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.25243109 |
105 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.23853437 |
106 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.22664443 |
107 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.21317033 |
108 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.20792121 |
109 | Leishmaniasis_Homo sapiens_hsa05140 | 0.19677256 |
110 | Parkinsons disease_Homo sapiens_hsa05012 | 0.18837826 |
111 | Galactose metabolism_Homo sapiens_hsa00052 | 0.18437765 |
112 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.16189671 |
113 | Alcoholism_Homo sapiens_hsa05034 | 0.15447404 |
114 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.15362253 |
115 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.13885447 |
116 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.13389344 |
117 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.12798422 |
118 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.12079320 |
119 | Insulin resistance_Homo sapiens_hsa04931 | 0.11174083 |
120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.11037307 |
121 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1351089 |
122 | Huntingtons disease_Homo sapiens_hsa05016 | -0.1345431 |
123 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.1342992 |
124 | Vibrio cholerae infection_Homo sapiens_hsa05110 | -0.1097795 |
125 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | -0.1018876 |
126 | Cardiac muscle contraction_Homo sapiens_hsa04260 | -0.1003029 |
127 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0814881 |
128 | Choline metabolism in cancer_Homo sapiens_hsa05231 | -0.0727095 |
129 | Gastric acid secretion_Homo sapiens_hsa04971 | -0.0458396 |
130 | Alzheimers disease_Homo sapiens_hsa05010 | -0.0372966 |
131 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0355288 |
132 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0068827 |